The Promise of a Pill
The newest buzz in obesity medicine is Orforglipron, Eli Lilly’s once daily oral pill designed to help with weight loss. Early studies show an average 12.4 percent weight reduction over 72 weeks. That is a significant drop, though it trails behind injectable medications like Wegovy and Mounjaro, which often reach 15 to 20 percent or more.
Still, the appeal is obvious. Many patients are hesitant to inject themselves each week. A pill you swallow each morning feels simple, familiar, and convenient.
The Trade Offs
Convenience does not always mean more effective. While Orforglipron shows promise, results so far suggest it may not match the full strength of injectable GLP1 and GLP1 GIP medications. Side effects, mostly nausea and stomach upset, are still common. About one in ten participants stopped taking the medication due to tolerability.
This reinforces an important lesson in weight management. Success comes not only from choosing a powerful drug, but also from finding one you can comfortably stay on long term with the right support.
What This Means Today
Orforglipron is not yet FDA approved, though Eli Lilly is preparing a regulatory filing. That means it may still be some time before patients can access it outside of a trial setting. For now, the most effective and widely available options remain the established injectables such as Ozempic, Wegovy, Zepbound, and Mounjaro.
The Achieve Difference
At Achieve Health and Weight Loss, we track these breakthroughs closely. We help patients make sense of the options and choose what is best for them today, while keeping an eye on what is coming tomorrow.
Our members benefit from:
- Physician oversight by a double board-certified expert in obesity and internal medicine
- Access to safe, effective and scientifically proven medications
- Remote monitoring with a body composition scale to track fat loss
- One on one health coaching for nutrition, lifestyle, and accountability
- Careful titration of medication to minimize side effects
Our members see on average 20 percent or greater weight loss, results that go beyond the scale and improve long term health.
The Bottom Line
Orforglipron is exciting and may reshape the weight loss landscape in the future. But today, patients do not need to wait for innovation. Achieve provides access to the safest and most effective treatments now, paired with ongoing medical guidance and support.
👉 Ready to take control of your health today? Join Achieve Health and Weight Loss and get started with a program proven to deliver real results.
